Neuronal and microglial mechanisms of neuropathic pain
- PMID: 21801430
- PMCID: PMC3163530
- DOI: 10.1186/1756-6606-4-31
Neuronal and microglial mechanisms of neuropathic pain
Abstract
Neuropathic pain is generally defined as a chronic pain state resulting from peripheral and/or central nerve injury. Effective treatment for neuropathic pain is still lacking, due in part to poor understanding of pathological mechanisms at the molecular level. Neuronal mechanisms of neuropathic pain, especially synaptic plasticity, are the major focus of many investigators. N-methyl-D-aspartate (NMDA) receptor dependent synaptic plasticity at the spinal and cortical levels is believed to contribute to enhanced sensory responses after injury. Glial cells, including astrocytes and microglia, have recently been implicated in neuropathic pain. These glial cells form close interactions with neurons and thus may modulate nociceptive transmission under pathological conditions. In this review, we present recent progress in the study of neuronal and microglial mechanisms underlying neuropathic pain. We propose that activity-dependent neuronal plasticity is a key target for treatment in neuropathic pain.
Figures



Similar articles
-
Wnt/Ryk signaling contributes to neuropathic pain by regulating sensory neuron excitability and spinal synaptic plasticity in rats.Pain. 2015 Dec;156(12):2572-2584. doi: 10.1097/j.pain.0000000000000366. Pain. 2015. PMID: 26407042
-
Targeting the NMDA receptor subunit NR2B for the treatment of neuropathic pain.Neurotherapeutics. 2009 Oct;6(4):693-702. doi: 10.1016/j.nurt.2009.07.008. Neurotherapeutics. 2009. PMID: 19789073 Free PMC article. Review.
-
Neuronal-Glial Interactions Maintain Chronic Neuropathic Pain after Spinal Cord Injury.Neural Plast. 2017;2017:2480689. doi: 10.1155/2017/2480689. Epub 2017 Aug 29. Neural Plast. 2017. PMID: 28951789 Free PMC article. Review.
-
Role of the spinal cord NR2B-containing NMDA receptors in the development of neuropathic pain.Exp Neurol. 2009 Feb;215(2):298-307. doi: 10.1016/j.expneurol.2008.10.018. Epub 2008 Nov 12. Exp Neurol. 2009. PMID: 19046970
-
[Neuropharmacological study of ATP receptors and their role in neuropathic pain].Yakugaku Zasshi. 2013;133(10):1035-9. doi: 10.1248/yakushi.13-00191. Yakugaku Zasshi. 2013. PMID: 24088347 Review. Japanese.
Cited by
-
Targeting the Microglial Signaling Pathways: New Insights in the Modulation of Neuropathic Pain.Curr Med Chem. 2016;23(26):2908-2928. doi: 10.2174/0929867323666160607120124. Curr Med Chem. 2016. PMID: 27281131 Free PMC article. Review.
-
Utilizing multiphoton imaging and integrative clearing to reveal sex differences in neuroimmune interactions after nerve injury.Neural Regen Res. 2022 Nov;17(11):2429-2430. doi: 10.4103/1673-5374.335809. Neural Regen Res. 2022. PMID: 35535886 Free PMC article. No abstract available.
-
Implication of microglia activation and CSF-1/CSF-1Rpathway in lumbar disc degeneration-related back pain.Mol Pain. 2018 Jan-Dec;14:1744806918811238. doi: 10.1177/1744806918811238. Epub 2018 Oct 17. Mol Pain. 2018. PMID: 30326776 Free PMC article.
-
Brain Microglial Activation in Chronic Pain-Associated Affective Disorder.Front Neurosci. 2019 Mar 15;13:213. doi: 10.3389/fnins.2019.00213. eCollection 2019. Front Neurosci. 2019. PMID: 30949019 Free PMC article.
-
Downregulation of M-channels in lateral habenula mediates hyperalgesia during alcohol withdrawal in rats.Sci Rep. 2019 Feb 25;9(1):2714. doi: 10.1038/s41598-018-38393-7. Sci Rep. 2019. PMID: 30804373 Free PMC article.
References
-
- McCarberg BH, Billington R. Consequences of neuropathic pain: quality-of-life issues and associated costs. Am J Manag Care. 2006;12:S263–268. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources